Complete your stack
- Tirzepatide $109.99 Coming soon
- Retatrutide $109.99 Coming soon
- YK11 - Myostine $109.99
GLO (TB-500 + BPC-157 + Copper GHk Peptide Blend)
$109.99
GLO is a triple-action research blend of TB-500, BPC-157 and Copper GHK-Cu, three of the most-studied regenerative peptides, combined in one vial for recovery, skin and cellular-repair research. Premium Canadian research peptides, third-party tested and shipped fast across Canada.
Description
Three of the most talked-about regenerative peptides, one vial: GLO combines TB-500, BPC-157 and Copper GHK-Cu into a single research-grade blend engineered for recovery, skin-health and cellular-repair investigation. If you want the full regenerative toolkit without juggling three separate reconstitutions, GLO (TB-500 + BPC-157 + Copper GHk Peptide Blend) Canada is the streamlined answer: high-purity, third-party verified Canadian research peptides, shipped fast and backed by transparent documentation.1
What Is GLO (TB-500 + BPC-157 + Copper GHk Peptide Blend)?
GLO is a proprietary peptide blend that pairs three regenerative compounds studied individually for tissue repair and anti-aging signalling: TB-500 (a Thymosin Beta-4 fragment), BPC-157 (Body Protection Compound-157), and Copper GHK-Cu (the glycyl-L-histidyl-L-lysine copper tripeptide). Each targets a different node of the body’s repair machinery: TB-500 is associated with angiogenesis and recovery, BPC-157 with gut and musculoskeletal healing, and Copper GHK-Cu with collagen synthesis and skin regeneration. Combined in one vial, they are studied together as a model for how overlapping regenerative pathways interact. GLO is supplied strictly for laboratory, research and educational use only; it is not for human consumption.
How GLO Works
The three peptides in GLO act through complementary, non-identical mechanisms. TB-500 corresponds to the actin-binding region of Thymosin Beta-4 and is studied for promoting cell migration and new blood-vessel formation (angiogenesis) at sites of tissue stress. BPC-157 is a synthetic pentadecapeptide derived from a sequence in gastric juice; in laboratory models it has been reported to upregulate vascular endothelial growth factor receptor 2 (VEGFR2), a key switch in the angiogenic cascade that supports endothelial repair.1 Copper GHK-Cu delivers copper ions in a bioavailable tripeptide form and is studied for stimulating collagen and glycosaminoglycan synthesis in dermal fibroblasts. The working research hypothesis behind the blend is that angiogenic signalling (TB-500), cytoprotective repair signalling (BPC-157) and extracellular-matrix remodelling (Copper GHK-Cu) may be observed in parallel within a single experimental model. Mechanistic data for the combination itself remain limited, so any interaction effects are a subject for investigation rather than established fact.
What the Research Shows
- BPC-157 and angiogenesis. In laboratory work, BPC-157 has been shown to activate VEGFR2 and downstream endothelial pathways associated with vascular repair.1
- Individual, not combined, evidence. The published literature examines TB-500, BPC-157 and Copper GHK-Cu largely as separate compounds; controlled studies on this specific three-way blend are not currently available. Component compound records can be reviewed independently via PubChem.2
- Preclinical stage. Most available data are from cell-culture and animal models rather than human trials. Readers are encouraged to survey the primary literature directly before drawing conclusions.3
Researchers comparing regenerative and recovery-oriented peptides often evaluate GLO alongside its standalone components TB-500 and BPC-157, or next to growth-hormone-secretagogue protocols such as CJC-1295 and Ipamorelin.
Chemical Properties
| Research Name | GLO (TB-500 + BPC-157 + Copper GHk Peptide Blend) |
| CAS Number | Blend — TB-500 (Thymosin β4): 77591-33-4; BPC-157: 137525-51-0; Copper GHK-Cu: 49557-75-7 |
| Molecular Formula | Blend — TB-500: C212H350N56O78S; BPC-157: C62H98N16O22; Copper GHK-Cu: C14H24CuN6O4 |
| Molecular Weight | Blend — TB-500: 4963.4 g/mol; BPC-157: 1419.55 g/mol; Copper GHK-Cu: 403.86 g/mol |
| Classification | Proprietary regenerative peptide blend (research chemical) |
Research Protocols & Handling
GLO is intended solely for in-vitro and laboratory research and educational purposes. It is not a drug, supplement, cosmetic or food, and it is not for human or veterinary use. Supplied as a lyophilised powder, the blend is typically reconstituted with bacteriostatic water and gently swirled, never shaken, until fully dissolved. Store the sealed lyophilised vial frozen or refrigerated and protected from light; once reconstituted, keep refrigerated at 2–8°C and use within a limited window to preserve peptide integrity. Because Copper GHK-Cu is a copper complex, avoid unnecessary exposure to strong oxidisers or extreme pH during handling. Always follow standard laboratory safety practice, including gloves and appropriate documentation of lot and concentration.
Potential Side Effects & Safety
Honesty matters: although marketed peptides are often described as well tolerated in research settings, they are not risk-free, and the safety profile of this specific blend has not been established in controlled human studies. Reported and plausible effects include:
- Injection-site reactions. The most commonly documented issue for peptides of this class is local irritation at the handling or administration site: redness, swelling, itching, transient pain or bruising. Copper-containing peptides such as GHK-Cu can also cause localised stinging or contact sensitivity in some contexts.
- Unknown combination effects. Because GLO combines three actives, interaction effects and cumulative sensitivities are not fully characterised and remain an open research question.
- General caution. As with any bioactive research peptide, effects on immune signalling, blood vessels and tissue growth are theoretically possible and unquantified in humans.
Not approved for human consumption in Canada or elsewhere; research and educational use only.
Frequently Asked Questions
Is GLO legal in Canada?
GLO (TB-500 + BPC-157 + Copper GHk Peptide Blend) Canada is sold strictly as a research chemical for laboratory and educational use. It is not approved by Health Canada as a drug, supplement or cosmetic, and it is not authorised for human or veterinary consumption. Purchasers are responsible for complying with all applicable local, provincial and federal regulations governing research materials.
What makes GLO different from buying the peptides separately?
Is there published research on the GLO blend specifically?
How should GLO be stored?
Keep the lyophilised powder frozen or refrigerated and away from light. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within a short window to maintain peptide stability.
References
Peer-reviewed and authoritative sources cited above. Helixx supplies research materials for laboratory and educational use only; citations are provided for independent verification, not as medical guidance.
- Hsieh MJ, et al. Stable gastric pentadecapeptide BPC 157 exerts angiogenic effects via VEGFR2 activation. J Mol Med. 2017. PMID: 27847966.
- PubChem Compound records (component peptides) — BPC-157 (CID 9941957), Thymosin Beta-4 / TB-500, and Copper GHK-Cu. National Library of Medicine. pubchem.ncbi.nlm.nih.gov.
- PubMed literature search for the component peptides (TB-500, BPC-157, GHK-Cu). National Library of Medicine. pubmed.ncbi.nlm.nih.gov.